Connect with us
Information

Australia
North America
World

Investing News NetworkYour trusted source for investing success

North America
Australia
World
My INN

Private Placements

Reports & Guides
- Market Outlook Reports
- Investing Guides
Button

Precious Metals
Battery Metals
Base Metals
Energy
Critical Minerals

Company Profiles Market

Company Profiles News

Company Profiles Stocks

Company Profiles Market
Company Profiles News
Company Profiles Stocks

Home
Company Profiles

ambrx biopharma inc.

ambrx biopharma inc.

NYSE:AMAM

Ambrx Biopharma Inc.

Chart

Detailed Quote

Featured Articles and Interviews

A hand holding a double helix.

Dec 07, 2023

Top 5 NASDAQ Genetics Stocks (Updated December 2023)

hand holding double helix

Apr 05, 2023

Top 5 NASDAQ Genetics Stocks (Updated March 2023)

Press Releases

Dec 16, 2022

Ambrx Biopharma Inc. Announces Receipt of NYSE Non-Compliance Letter Regarding ADS Trading Price

Dec 09, 2022

Ambrx Announces Encouraging Preliminary Safety and Efficacy Data Evaluating ARX788 in HER2 Positive Metastatic Breast Cancer Patients Who Progressed Following T-DM1 Treatment

Nov 29, 2022

Interim Data from Ambrx's Study of ARX788 selected for Spotlight Poster Discussion at the 2022 San Antonio Breast Cancer Symposium

See More Press Releases

The Conversation (0)

Alert Options

No alert set

INN Article Notification

Instant Daily Weekly

Alert Option

You will be notified when this event occurs. No additional settings needed.